Amp Energy India commissions open-access solar project for Bharat Serums and Vaccines

Share

Amp Energy India announced this week it has commissioned a 5 MW solar power plant for Bharat Serum and Vaccines Ltd (BSV), one of India’s leading vaccine biopharmaceutical majors. The solar project is located in the Osmanabad district of Maharashtra and supplies solar power to BSV’s manufacturing facility in Ambernath, Maharashtra, under open access.

The PV plant will meet about 65% of BSV’s annual energy needs and will help it achieve 35% savings on its overall energy costs on a year-on-year basis. The plant will also help BSV offset about 6,560 metric tons of CO2 per annum, stated the developer.

Amp Energy India is headquartered in New Delhi with regional offices in Mumbai, Bangalore, and Kolkata. It has a total renewables portfolio of 2 GW+ spread across 15 states in India, which includes a balanced mix of C&I and utility-scale projects.

Amp Energy India provides renewable energy solutions across technologies such as solar, wind, hybrids, storage, and energy management.

 

This content is protected by copyright and may not be reused. If you want to cooperate with us and would like to reuse some of our content, please contact: editors@pv-magazine.com.

Popular content

INOXGFL Group enters solar manufacturing
11 December 2024 INOX Solar, an INOXGFL Group promoter-owned company, targets initial manufacturing capacities of 5 GW of solar modules and 2.5 GW of solar cells by 20...